Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30
Published August 29, 2018 · Recall initiated: August 14, 2018
Summary
FDA records drug Class III recall D-1103-2018, published August 29, 2018 and initiated August 14, 2018. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 10,577 bottles; Lot: Lot #: VR117014A, VR117015A, Exp. 08/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Distributor
- Product was distributed throughout the United States to wholesalers and retailers.
- Lot
- Lot #: VR117014A, VR117015A, Exp. 08/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAProchlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc.,January 11, 2023
- FDAIrbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAIrbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAMethylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant CadistaApril 13, 2022
- FDAValsartan Tablets USP, 80 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661August 29, 2018
- FDATomoSPOT REF 782, 782S, 783, 783S, 784, 784S, 785 & 785S Adhere to skin for marking and identifying moles inAugust 22, 2018
Questions about this recall
Was Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30 recalled?
Yes. FDA published recall D-1103-2018 on August 29, 2018. Reported hazard: Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter